Objective: To assess the effect of pharmacist screening for osteoporosis risk with increased bone mineral density (BMD) testing.
Design: Prospective, quasi-experiment.
Setting: Veterans Affairs medical center Community Living Centers (CLC), home-based primary care, and outpatient geriatric clinic.